- US12187799utility2025Dual Specificity Antibodies to PD-L1 and PD-L2 and Methods of Use Therefor0 cites
- US12187888utility2025Development and Characterization of F-gelatin Electrospun Scaffolds for Cardiac Tissue Modeling0 cites
- US12178787utility2024T Cell Receptors for Immunotherapy0 cites
- US12178848utility2024Methods and Compositions for the Treatment of Exocrine Pancreatic Insufficiency0 cites
- US12178868utility2024Immunogenic Compositions and Uses Thereof0 cites
- US12179037utility2024Radiotherapies and Uses Thereof0 cites
- US12180277utility2024Lilrb4-binding Antibody and Methods of Use Thereof0 cites
- US12181421utility2024Test Capsules for Measuring a Change in at Least One Property of a Material, and Related Methods0 cites
- US12171803utility2024Methods of CD40 and Toll Like Receptor Immune Activation0 cites
- US12173061utility2024Compositions and Methods for Treatment of Chronic Lung Diseases0 cites
- US12173084utility2024Phosphorylated Dicer Antibody and Methods of Use Thereof0 cites
- US12173087utility2024Melanocortin 1 Receptor Ligands and Methods of Use0 cites
- US12173089utility2024Inhibition of Pulmonary Fibrosis with Nutlin-3a and Peptides0 cites
- US12173317utility2024Use of Histone Modifiers to Reprogram Effector T Cells0 cites
- US12168244utility2024Nanoscale Thin Film Deposition Systems0 cites
- US12168678utility2024Heme Sequesting Peptides and Uses Therefor0 cites
- US12168691utility2024VHS Format Bi-specific Antibodies Specific for HER2 and VEGF and Use Thereof0 cites
- US12169202utility2024Measurement of 2-hydroxyglutarate Enantiomer Levels as a Biomarker for IDH Mutant Cancers0 cites
- US12163168utility2024Engineered Primate Cystine/cysteine Degrading Enzymes for Therapeutic Uses0 cites